Prolonged combination anti-platelet therapy following per-cutaneous coronary intervention (PCI) is impractical in the elderly.
A prolonged course of anti-platelet therapy is increasingly recommended following per-cutaneous coronary intervention based on the evidence from several clinical trials. However, the practicality and risk of such therapy in unselected patient population is as yet unclear. This study shows that such prolonged regimes of anti-platelet therapy are not practical in the elderly sub-group of patients.
Saravanan
Palaniappan
P
Mirjafari
Hoda
H
Prendergast
Bernard D
BD
D000367:Age Factors; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000379:methods*; D003131:Combined Modality Therapy / Q000009:adverse effects / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors